Pharmacist-Led Interventions for the Management of Cardiovascular Disease

McConnell, Karen; Denham, Anne M; Olson, Kari L.

doi:10.2165/00115677-200816030-00001

Cited by 7 publications

(8 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…22 Furthermore, our findings are supported by a recent systematic review 53 ence between the pharmacist group and the comparison group of −6.3 mg/dL (95% CI, −6.5 to −6.0) in LDL-C, −7.8 mm Hg (95% CI, −9.7 to −5.8) in systolic BP, and −2.9 mm Hg (95% CI, −3.8 to −2.0) in diastolic BP. Nevertheless, this review was restricted to studies conducted in the United States and evaluated only interventions of pharmacist as a team member, ie, pharmacist-collaborative care interventions.…”

Section: Commentmentioning

confidence: 99%

“…A review of pharmacist interventions suggested that pharmacy-based interventions improve surrogate outcomes of CVD. 22 However, this review was not systematic in its coverage and did not aggregate the findings through metaanalysis. Therefore, we conducted a systematic review of randomized studies to determine the impact of pharmacist care on the management of major CVD risk factors among outpatients.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors

Santschi

2011

Arch Intern Med

261

129

View full text Add to dashboard Cite

show abstract

Section: Commentmentioning

confidence: 99%

mentioning

confidence: 99%

Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors

Santschi

2011

Arch Intern Med

261

129

View full text Add to dashboard Cite

show abstract

“…Another important aspect of teamwork effectiveness and uptake is the model of remuneration or the provision of incentives. The model of reimbursement has been described in two reviews [43,51] as one of the barriers to collaborative care. Experiences in Australia and UK with new reimbursement models have been linked to team performance [15].…”

Section: Discussionmentioning

confidence: 99%

“…Sixteen systematic [33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48] and 7 narrative reviews were included in the overview [6,[49][50][51][52][53][54] (see flow diagram in Figure 1). While eight systematic reviews included only randomized controlled trials, six included both randomized and non-randomized trials.…”

Section: Characteristics Of Included Review Papersmentioning

confidence: 99%

Team Effectiveness in Patient Health Management: An Overview of Reviews

Gogovor

Burnand²,

Ahmed³

et al. 2012

IJCM

View full text Add to dashboard Cite

Background: The desire to improve the quality of health care for an aging population with multiple chronic diseases is fostering a rapid growth in interprofessional team care, supported by health professionals, governments, businesses and public institutions. However, the weight of evidence measuring the impact of team care on patient and health system outcomes has not, heretofore, been clear. To address this deficiency, we evaluated published evidence for the clinical effectiveness of team care within a chronic disease management context in a systematic overview. Methods: A search strategy was built for Medline using medical subject headings and other relevant keywords. After testing for performance, the search strategy was adapted to other databases (Cinhal, Cochrane, Embase, PsychInfo) using their specific descriptors. The searches were limited to reviews published between 1996 and 2011, in English and French languages. The results were analyzed by the number of studies favouring team intervention, based on the direction of effect and statistical significance for all reported outcomes. Results: Sixteen systematic and 7 narrative reviews were included. Diseases most frequently targeted were depression, followed by heart failure, diabetes and mental disorders. Effectiveness outcome measures most commonly used were clinical endpoints, resource utilization (e.g., emergency room visits, hospital admissions), costs, quality of life and medication adherence. Briefly, while improved clinical and resource utilization endpoints were commonly reported as positive outcomes, mixed directional results were often found among costs, medication adherence, mortality and patient satisfaction outcomes. Conclusions: We conclude that, although suggestive of some specific benefits, the overall weight of evidence for team care efficacy remains equivocal. Further studies that examine the causal interactions between multidisciplinary team care and clinical and economic outcomes of disease management are needed to more accurately assess its net program efficacy and population effectiveness.

show abstract

“…16 Pharmacists worked in a collaborative practice model to help patients achieve a 4-fold increase in the number of patients obtaining LDL-C goals compared to the control cohort. 17,18 As the new guidelines are implemented patients and health care providers may become confused about monitoring and proper initiation of statin therapy. Pharmacists can prepare to provide education to patients and the health care team on guideline updates and implement lipid management services for patients.…”

Section: National Cholesterol Guidelinesmentioning

confidence: 99%

Pharmacists Role in Cholesterol Management

Manigault

2014

Journal of Pharmacy Practice

View full text Add to dashboard Cite

Cholesterol management is an important factor in the modification of primary and secondary cardiovascular events. Guidelines emphasize incorporation of appropriate medication therapy and lifestyle adjustments to reduce low-density lipoprotein cholesterol (LDL-C) for cardiovascular disease (CVD) risk reduction. Of note, studies and nation-wide statistics indicate many patients do not achieve their LDL-C goals. Eliminating barriers and challenges associated with cholesterol management will allow patients to reach prespecified goals for CVD risk reduction. As the nation transitions to covering more individuals, the need for additional health care providers is evident. Pharmacists are accessible and knowledgeable health care contributors who can assist in optimizing patient outcomes. This article discusses the pharmacist's role in addressing challenges and barriers in cholesterol management.

show abstract

Pharmacist-Led Interventions for the Management of Cardiovascular Disease

Cited by 7 publications

References 53 publications

Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors

Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors

Team Effectiveness in Patient Health Management: An Overview of Reviews

Pharmacists Role in Cholesterol Management

Contact Info

Product

Resources

About